Intercure
INCR • NASDAQ
Intercure is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Alexander Rabinovich, with a market cap of $48.3M.
CEOAlexander Rabinovich
Next Earnings
Upcoming earnings announcement for Intercure
Date
Monday, February 23, 2026 (in 1 week)
Timing
After Market Close (5:00 PM New York)
Fiscal Period
FY 2025
Earnings History
Past 7 earnings reports for Intercure
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Oct 8, 2025 | H1 2025 | $0.01 | — | $36.3MEst: $66.5M | -45.5% | — |
| May 1, 2025 | FY 2024 | -$0.40 | — | $64.5M | — | — |
| Aug 29, 2024 | H1 2024 | $0.00 | — | $34.0M | — | — |
| Aug 31, 2023 | Q2 2023 | $0.03 | — | $28.1M | — | — |
| May 15, 2023 | Q1 2023 | $0.00 | — | $30.1M | — | — |
| Mar 31, 2023 | Q4 2022 | $0.05 | — | $30.3M | — | — |
| Nov 15, 2022 | Q3 2022 | $0.05 | — | $29.6M | — | — |